Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
25 Sep 2021
Historique:
received: 07 08 2020
accepted: 03 09 2021
entrez: 26 9 2021
pubmed: 27 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Early identification of severe COVID-19 patients who will need intensive care unit (ICU) follow-up and providing rapid, aggressive supportive care may reduce mortality and provide optimal use of medical resources. We aimed to develop and validate a nomogram to predict severe COVID-19 cases that would need ICU follow-up based on available and accessible patient values. Patients hospitalized with laboratory-confirmed COVID-19 between March 15, 2020, and June 15, 2020, were enrolled in this retrospective study with 35 variables obtained upon admission considered. Univariate and multivariable logistic regression models were constructed to select potential predictive parameters using 1000 bootstrap samples. Afterward, a nomogram was developed with 5 variables selected from multivariable analysis. The nomogram model was evaluated by Area Under the Curve (AUC) and bias-corrected Harrell's C-index with 95% confidence interval, Hosmer-Lemeshow Goodness-of-fit test, and calibration curve analysis. Out of a total of 1022 patients, 686 cases without missing data were used to construct the nomogram. Of the 686, 104 needed ICU follow-up. The final model includes oxygen saturation, CRP, PCT, LDH, troponin as independent factors for the prediction of need for ICU admission. The model has good predictive power with an AUC of 0.93 (0.902-0.950) and a bias-corrected Harrell's C-index of 0.91 (0.899-0.947). Hosmer-Lemeshow test p-value was 0.826 and the model is well-calibrated (p = 0.1703). We developed a simple, accessible, easy-to-use nomogram with good distinctive power for severe illness requiring ICU follow-up. Clinicians can easily predict the course of COVID-19 and decide the procedure and facility of further follow-up by using clinical and laboratory values of patients available upon admission.

Sections du résumé

BACKGROUND BACKGROUND
Early identification of severe COVID-19 patients who will need intensive care unit (ICU) follow-up and providing rapid, aggressive supportive care may reduce mortality and provide optimal use of medical resources. We aimed to develop and validate a nomogram to predict severe COVID-19 cases that would need ICU follow-up based on available and accessible patient values.
METHODS METHODS
Patients hospitalized with laboratory-confirmed COVID-19 between March 15, 2020, and June 15, 2020, were enrolled in this retrospective study with 35 variables obtained upon admission considered. Univariate and multivariable logistic regression models were constructed to select potential predictive parameters using 1000 bootstrap samples. Afterward, a nomogram was developed with 5 variables selected from multivariable analysis. The nomogram model was evaluated by Area Under the Curve (AUC) and bias-corrected Harrell's C-index with 95% confidence interval, Hosmer-Lemeshow Goodness-of-fit test, and calibration curve analysis.
RESULTS RESULTS
Out of a total of 1022 patients, 686 cases without missing data were used to construct the nomogram. Of the 686, 104 needed ICU follow-up. The final model includes oxygen saturation, CRP, PCT, LDH, troponin as independent factors for the prediction of need for ICU admission. The model has good predictive power with an AUC of 0.93 (0.902-0.950) and a bias-corrected Harrell's C-index of 0.91 (0.899-0.947). Hosmer-Lemeshow test p-value was 0.826 and the model is well-calibrated (p = 0.1703).
CONCLUSION CONCLUSIONS
We developed a simple, accessible, easy-to-use nomogram with good distinctive power for severe illness requiring ICU follow-up. Clinicians can easily predict the course of COVID-19 and decide the procedure and facility of further follow-up by using clinical and laboratory values of patients available upon admission.

Identifiants

pubmed: 34563117
doi: 10.1186/s12879-021-06656-w
pii: 10.1186/s12879-021-06656-w
pmc: PMC8467006
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1004

Informations de copyright

© 2021. The Author(s).

Références

Front Public Health. 2020 Aug 11;8:461
pubmed: 32850612
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Sci Rep. 2020 Sep 14;10(1):15058
pubmed: 32929124
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Int J Med Sci. 2020 May 18;17(9):1281-1292
pubmed: 32547323
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Front Public Health. 2020 Nov 24;8:574915
pubmed: 33330318
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399
pubmed: 32271369
J Transl Med. 2020 Aug 31;18(1):328
pubmed: 32867787
J Med Virol. 2021 Apr;93(4):2332-2339
pubmed: 33289142
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Crit Care. 2020 Mar 18;24(1):108
pubmed: 32188484
Emerg Infect Dis. 2020 Jun;26(6):1251-1256
pubmed: 32168464
J Clin Virol. 2020 Jun;127:104371
pubmed: 32315817
BMC Infect Dis. 2021 Feb 5;21(1):148
pubmed: 33546639
Clin Infect Dis. 2020 Nov 19;71(16):2079-2088
pubmed: 32361723
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Clin Infect Dis. 2021 Feb 16;72(4):652-660
pubmed: 32649738
Aging (Albany NY). 2021 Feb 9;13(3):3176-3189
pubmed: 33561834
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Ann Med. 2020 Nov;52(7):367-375
pubmed: 32723107
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
PLoS One. 2020 May 18;15(5):e0233328
pubmed: 32421703
Clin Infect Dis. 2020 Jul 28;71(15):833-840
pubmed: 32296824
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
BMC Med Imaging. 2020 Oct 2;20(1):111
pubmed: 33008329
Scand J Trauma Resusc Emerg Med. 2020 Oct 27;28(1):106
pubmed: 33109234
Life Sci. 2020 Aug 1;254:117788
pubmed: 32475810
Stat Med. 2002 Sep 30;21(18):2723-38
pubmed: 12228887
Eur Respir J. 2020 Aug 20;56(2):
pubmed: 32616597

Auteurs

Rahmet Guner (R)

Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.

Bircan Kayaaslan (B)

Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey. drbican@gmail.com.

Imran Hasanoglu (I)

Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.

Adalet Aypak (A)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Hurrem Bodur (H)

Department of Infectious Disease and Clinical Microbiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Ihsan Ates (I)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Esragul Akinci (E)

Department of Infectious Disease and Clinical Microbiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Deniz Erdem (D)

Department of Anesthesiology and Reanimation, Ankara City Hospital, Ankara, Turkey.

Fatma Eser (F)

Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.

Seval Izdes (S)

Department of Anesthesiology and Reanimation and Intensive Care Unıt, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey.

Ayse Kaya Kalem (AK)

Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.

Aliye Bastug (A)

Department of Infectious Disease and Clinical Microbiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Aysegul Karalezli (A)

Department of Pulmonary Diseases, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey.

Aziz Ahmet Surel (AA)

Department of General Surgery, Ankara City Hospital, Ankara, Turkey.

Muge Ayhan (M)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Selma Karaahmetoglu (S)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Isıl Ozkocak Turan (IO)

Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Emine Arguder (E)

Department of Anesthesiology and Reanimation and Intensive Care Unıt, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey.

Burcu Ozdemir (B)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Mehmet Nevzat Mutlu (MN)

Department of Anesthesiology and Reanimation, Ankara City Hospital, Ankara, Turkey.

Yesim Aybar Bilir (YA)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Elif Mukime Sarıcaoglu (EM)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Derya Gokcinar (D)

Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Sibel Gunay (S)

Department of Pulmonary Diseases, Ankara City Hospital, Ankara, Turkey.

Bedia Dinc (B)

Department of Microbiology, Ankara City Hospital, Ankara, Turkey.

Emin Gemcioglu (E)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Ruveyda Bilmez (R)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Omer Aydos (O)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Dilek Asilturk (D)

Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.

Osman Inan (O)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Turan Buzgan (T)

Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH